ENVESTNET ASSET MANAGEMENT INC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 108 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$778,389
+43.2%
16,925
+79.0%
0.00%
Q2 2023$543,494
+59.7%
9,457
+4.2%
0.00%
Q1 2023$340,388
+61.3%
9,077
+50.0%
0.00%
Q2 2022$211,000
-11.3%
6,053
-8.6%
0.00%
Q1 2022$238,000
+4660.0%
6,621
+2527.4%
0.00%
Q2 2017$5,000
+25.0%
252
-6.7%
0.00%
Q1 2017$4,0000.0%270
+39.9%
0.00%
Q4 2016$4,000
-97.4%
193
-98.0%
0.00%
-100.0%
Q2 2016$155,000
+34.8%
9,6220.0%0.00%
Q1 2016$115,0009,6220.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2017
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders